Kingswood Wealth Advisors LLC Has $3.22 Million Stake in CVS Health Corporation (NYSE:CVS)

Kingswood Wealth Advisors LLC increased its position in CVS Health Corporation (NYSE:CVS - Free Report) by 111.7% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 47,336 shares of the pharmacy operator's stock after purchasing an additional 24,975 shares during the period. Kingswood Wealth Advisors LLC's holdings in CVS Health were worth $3,216,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. LaFleur & Godfrey LLC boosted its stake in CVS Health by 49.9% in the 4th quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock worth $217,000 after purchasing an additional 1,610 shares during the period. Principal Securities Inc. boosted its stake in CVS Health by 3.2% in the 4th quarter. Principal Securities Inc. now owns 27,881 shares of the pharmacy operator's stock worth $1,252,000 after purchasing an additional 859 shares during the period. Allworth Financial LP boosted its stake in CVS Health by 23.7% in the 4th quarter. Allworth Financial LP now owns 21,795 shares of the pharmacy operator's stock worth $978,000 after purchasing an additional 4,182 shares during the period. CIBC Asset Management Inc boosted its stake in shares of CVS Health by 2.3% during the 4th quarter. CIBC Asset Management Inc now owns 219,689 shares of the pharmacy operator's stock valued at $9,862,000 after buying an additional 4,967 shares during the period. Finally, Atria Wealth Solutions Inc. boosted its stake in shares of CVS Health by 62.3% during the 4th quarter. Atria Wealth Solutions Inc. now owns 62,160 shares of the pharmacy operator's stock valued at $2,790,000 after buying an additional 23,849 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on CVS. Truist Financial lifted their target price on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. Royal Bank Of Canada lifted their target price on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Piper Sandler lifted their target price on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.15 on Friday, hitting $66.69. 11,828,346 shares of the company were exchanged, compared to its average volume of 10,963,289. The company's 50 day moving average price is $64.98 and its two-hundred day moving average price is $60.35. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The firm has a market capitalization of $84.36 billion, a price-to-earnings ratio of 15.92, a PEG ratio of 0.96 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 EPS. Research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The shares were bought at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.